This is an interesting opinion piece which carriers some merit with some new observations about risk management and how individuals with an entire sequencing could stand to change the picture, although we are a bit away from having this available to all citizens in the US. Again, it all revolves...
The Medical Quack .... by Barbara Duck
The Medical Quack
Wed, Jul 15 2009
Filed under: Filed under: Medically Related, Insurance, personalized medicine, Genomics, healthcare, health insurance, Pharmacogenomics, treatments, Obama Healthcare Reform, asymmetric data, risk managment, pharmeceuticals